Key Developments For The Goldman Sachs Group, Inc.
The Goldman Sachs Group, Inc. (GS) (NYSE Arca)
Ratiopharm Attracts At Least 10 First Round Bids Including The Goldman Sachs Group, Inc.-Reuters
Reuters reported that German generic drug maker Ratiopharm has attracted at least 10 first-round bids. Bidders from the healthcare industry include Teva Pharmaceutical Industries Ltd., Mylan Inc., sanofi-aventis, SINOPHARM HOLDING CO., LIMITED and Actavis of Iceland. Buyout firms participating in the round of bids, which were non-binding, include TPG, Advent in collaboration with The Goldman Sachs Group, Inc., Permira and KKR. One source said EQT also filed a bid. Several sources close to the proceedings also told that most bids came in between EUR2 billion ($3 billion) and EUR2.5 billion. VEM owner Ludwig Merckle is selling Ratiopharm as part of concessions made by his late father to creditor banks.
Prysmian SpA's Main Shareholder Prysmian (Lux) II Sarl and Goldman Sachs Group, Inc.'s Goldman Sachs International to Sell Approximately 12% of the Company's Capital
Prysmian SpA announced that it has been informed by its majority shareholder, Prysmian (Lux) II Sarl, regarding the intension to sell, together with the other Company’s shareholder Goldman Sachs International, subsidiary of Goldman Sachs Group, Inc., part of the shares respectively held in Prysmian SpA, for an aggregate amount of approximately 12% of Prysmian SpA's share capital, through an accelerated book building procedure with Italian institutional investors and international institutional investors. The procedure started on November 9, 2009. The offer is being managed by Goldman Sachs International acting as Book Runner.
The Goldman Sachs Group, Inc. To Sell Stake In Shineway Group To CDH Investments-Reuters
Reuters reported that The Goldman Sachs Group, Inc. has agreed to sell half of its holding in Shineway Group, to a Chinese fund for about $150 million. Asia Special Situation Group (ASSG) of Goldman Sachs signed a deal last week to sell part of its stake in Shineway to CDH Investments. Goldman's sale of the stake will bring its holding in the parent to roughly 5% down from around 10%.
Berkshire Hathaway, Inc. Joins The Goldman Sachs Group, Inc.'s Bid For Fannie Mae's Tax Credits-Reuters
Reuters reported that Berkshire Hathaway, Inc. has joined The Goldman Sachs Group, Inc. in a bid to buy $3 billion in tax credits from Fannie Mae. The Treasury Department, which controls Fannie Mae and Freddie Mac after pouring $100 million into the housing-finance giants, may block the sale on the grounds that it wouldn't benefit taxpayers. The credits are worth little to Fannie Mae, which also records losses each quarter as their value declines.
NYSE Euronext Announces Equity Investment In Its U.S. Futures Exchange, NYSE Liffe U.S. By The Goldman Sachs Group, Inc. And Other Global Banks And Liquidity Providers
NYSE Euronext announced the signing of a binding agreement with several global banks and liquidity providers, Citadel Securities, GETCO, Goldman Sachs, Morgan Stanley, and UBS, to sell a significant equity interest in NYSE Liffe U.S., the U.S. futures exchange of NYSE Euronext. NYSE Euronext will remain the largest shareholder in the entity, which will bring substantial competitive and operational benefits to the marketplace. NYSE Euronext will continue to manage the day-to-day operations of NYSE Liffe U.S., which will operate under the supervision of a separate Board of Directors, chaired by Jim McNulty, and Chief Executive Officer Thomas F. Callahan. The transaction is expected to close shortly, subject to regulatory review.
